Wilson Sonsini Goodrich & Rosati advised ONL Therapeutics, Inc. on the deal. ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
